Legacy Ventures International Files Q1 2025 10-Q
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
Legacy Ventures Intl (LVGI) filed Q1 2025 10-Q. Financials updated.
AI Summary
Legacy Ventures International Inc. filed its Q1 2025 10-Q report for the period ending September 30, 2024. The company, incorporated in Nevada and operating in the Surgical & Medical Instruments & Apparatus sector, is headquartered in Markham, Ontario. The filing details financial information for the quarter and year-to-date periods, including common stock, additional paid-in capital, and retained earnings.
Why It Matters
This filing provides investors with an update on Legacy Ventures International's financial performance and position as of the end of the first fiscal quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags or significant new disclosures.
Key Numbers
- Q1 2025 — Fiscal Quarter (Period covered by the report)
- 2024-09-30 — Period End Date (The end date for the financial reporting period)
- 2024-12-30 — Filing Date (The date the report was officially submitted to the SEC)
Key Players & Entities
- LEGACY VENTURES INTERNATIONAL INC. (company) — Filer
- 20240930 (date) — Reporting Period End Date
- 20241230 (date) — Filing Date
- 3841 (other) — Standard Industrial Classification (SIC) Code for Surgical & Medical Instruments & Apparatus
- NV (other) — State of Incorporation
FAQ
What is the primary business of Legacy Ventures International Inc.?
Legacy Ventures International Inc. operates in the Surgical & Medical Instruments & Apparatus sector, as indicated by its SIC code 3841.
For which fiscal period is this 10-Q filing?
This 10-Q filing is for the first quarter of fiscal year 2025, ending on September 30, 2024.
When was this 10-Q report filed with the SEC?
This 10-Q report was filed on December 30, 2024.
Where is Legacy Ventures International Inc. incorporated?
Legacy Ventures International Inc. is incorporated in Nevada (NV).
What are the key financial statement components mentioned in the filing header?
The filing header mentions components such as Common Stock, Additional Paid-In Capital, and Retained Earnings for various reporting periods.
Filing Stats: 3,646 words · 15 min read · ~12 pages · Grade level 14.2 · Accepted 2024-12-30 06:13:09
Key Financial Figures
- $1,092 — rimary source of liquidity consisted of $1,092 (June 30, 2024 - $842) in cash. The Com
- $842 — ty consisted of $1,092 (June 30, 2024 - $842) in cash. The Company financed its oper
- $13,293 — r 30, 2024, cash used in operations was $13,293 and $9,836 for the three months ended S
- $9,836 — cash used in operations was $13,293 and $9,836 for the three months ended September 30
- $13,543 — ash provided by financing activities of $13,543 and $9,000, respectively for the three
- $9,000 — by financing activities of $13,543 and $9,000, respectively for the three months ende
- $20,465 — ee months ended September 30, 2024, was $20,465 compared with $6,744 for the three mont
- $6,744 — ber 30, 2024, was $20,465 compared with $6,744 for the three months ended September 30
- $6 — expenses. There were other expenses of $6 for the three months ended September 30
- $20,471 — ee months ended September 30, 2024, was $20,471, compared with net loss of $6,744 for t
Filing Documents
- form10-q.htm (10-Q) — 230KB
- ex31-1.htm (EX-31.1) — 12KB
- ex32-1.htm (EX-32.1) — 7KB
- 0001493152-24-052355.txt ( ) — 1418KB
- lgyv-20240930.xsd (EX-101.SCH) — 13KB
- lgyv-20240930_cal.xml (EX-101.CAL) — 19KB
- lgyv-20240930_def.xml (EX-101.DEF) — 34KB
- lgyv-20240930_lab.xml (EX-101.LAB) — 144KB
- lgyv-20240930_pre.xml (EX-101.PRE) — 114KB
- form10-q_htm.xml (XML) — 67KB
– FINANCIAL INFORMATION
PART I – FINANCIAL INFORMATION
Financial Statements
Item 1. Financial Statements 3
Management's Discussion and Analysis
Item 2. Management's Discussion and Analysis 10
Quantitative and Qualitative Disclosures About Market Risk
Item 3. Quantitative and Qualitative Disclosures About Market Risk 11
Controls and Procedures
Item 4. Controls and Procedures 11
– OTHER INFORMATION
PART II – OTHER INFORMATION
Legal Proceedings
Item 1. Legal Proceedings 12
Risk Factors
Item 1A. Risk Factors 12
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 12
Defaults Upon Senior Securities
Item 3. Defaults Upon Senior Securities 12
Mine Safety Disclosures
Item 4. Mine Safety Disclosures 12
Other Information
Item 5. Other Information 12
Exhibits
Item 6. Exhibits 12 2 PART I FINANCIAL INFORMATION ITEM 1. FINANCIAL STATEMENTS REQUIRED BY FORM 10-Q The Interim Condensed Consolidated Financial Statements of the Company are prepared as of September 30, 2024 CONTENTS Interim Condensed Consolidated Balance Sheets 4 Interim Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) 5 Interim Condensed Consolidated Statements of Stockholders' Deficiency 6 Interim Condensed Consolidated Statements of Cash Flows 7 Notes to the Interim Condensed Consolidated Financial Statements 8 3 LEGACY VENTURES INTERNATIONAL, INC. INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Express in United States Dollars ("US dollars"), except for number of shares) Note September 30, 2024 June 30, 2024 ASSETS Current assets Cash $ 1,092 $ 842 Total assets $ 1,092 $ 842 LIABILITIES AND STOCKHOLDERS' DEFICIENCY Current liabilities Accounts payable and accrued liabilities 4 $ 39,082 $ 31,904 Amount due to a director 4 1,282 1,282 Advances from a shareholder 4 118,068 104,525 Total liabilities $ 158,432 $ 137,711 Stockholders' deficiency Preferred Stock, $ 0.0001 par value; 10,000,000 shares authorized: Preferred Stock – no shares issued and outstanding September 30, 2024, and June 30, 2024 6 $ - $ - Common Stock, $ 0.0001 par value; 100,000,000 shares authorized: Common Stock – 50,315,064 shares issued and outstanding September 30, 2024 and June 30, 2024 6 5,032 5,032 Additional paid in capital 6,429,771 6,429,771 Accumulated deficit ( 6,592,143 ) ( 6,571,672 ) Total stockholders' deficiency ( 157,340 ) ( 136,869 ) Total liabilities and stockholders' deficiency $ 1,092 $ 842 Going Concern 2 Subsequent events 7 See accompanying notes to the unaudited interim condensed consolidated financial statements 4 LEGACY VENTURES INTERNATIONAL, INC. INTERIM CONDENSED CONSOLIDATED STATEMENTS OF
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. LEGACY VENTURES INTERNATIONAL, INC. Date: December 30, 2024 By: /s/ Hoi Sau KOO Name: Hoi Sau KOO Title: Chief Executive Officer, Chief Financial Officer 13